“…27,29 It is undeniable that the clinical practice of valve repair is globally insufficient and heterogeneous, with high-volume centers providing higher repair rates and lower operative mortality than low-volume centers. 8 Some centers report notable rates of residual or recurrent MR, 30 but in large mitral repair centers, recurrence of MR 20 and mitral reoperation rates are low, 2,20,29 between 5% and 10% at 10 years (lower than bioprostheses and equal to mechanical valves), 2 and rerepairs can be performed with good outcomes. 31 Furthermore, in large repair centers, repair rates Ն90% are achieved in most organic MR, particularly degenerative MR. 2,24,32 Whether minimally invasive mitral surgery, thoracoscopic or robotic, affects risk, discomfort, and durability of valve repair is uncertain.…”